After a drought of nearly a decade without an FDA approval, the market for hepatocellular carcinoma (HCC), the most common type of primary liver cancer in adults, is heating up. Read More
Talk with the administrators of any given U.S. hospital system, and you'll hear their frustration over shortages of essential medications developed in the 1950s, '60s and '70s – long off-patent – plaguing the U.S. health care system. Read More
